AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pharmacokinetic Study in Healthy Volunteers

Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal Function NCT07853131Phase 11 site📍 Hialeah Sanofi · Tests: rilzabrutinib A Study to Evaluate the Safety, Tolerability and PK of SK-08 NCT07021157Phase 11 site📍 Hangzhou Consun Pharmaceutical Group · Tests: SK-08, Placebo A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function NCT07694843Phase 11 site📍 Suzhou CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: ammoxetine hydrochloride enteric-coated tablets A Clinical Study of AK0610 NCT06996704Phase 11 site📍 Jinan Shanghai Ark Biopharmaceutical Co., Ltd. · Tests: AK0610 Injection solution, Placebo Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants NCT07174830Phase 41 site📍 Shenzhen Shenzhen Salubris Pharmaceuticals Co., Ltd. · Tests: Allisartan Isoproxil Tablets 240mg or placebo, Allisartan Isoproxil Tablets 480mg or placebo, Allisartan Isoproxil Tabl… A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers NCT07738991Phase 11 site📍 Zhengzhou Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. · Tests: NKF-PEG, US-Neulasta Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers NCT06857890Phase 11 site📍 Moscow Valenta Pharm JSC · Tests: Grammidin with anesthetic neo, Grammidin with anesthetic, a metered dose topical spray Pharmacokinetic Study of Sudapyridine(WX-081)in Healthy Chinese Subjects NCT06701110Phase 11 site📍 Suzhou Shanghai Jiatan Pharmatech Co., Ltd · Tests: [U-14C] WX-081 IPG1094 Phase I Study for China Healthy Participants NCT07679113Phase 11 site📍 Shanghai Nanjing Immunophage Biotech Co., Ltd · Tests: IPG1094 Tablets Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules NCT06823895Phase 11 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Maixuekang capsule A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function NCT07694869Phase 11 site📍 Hefei CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: ammoxetine hydrochloride enteric-coated tablets Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects NCT07301203Phase 11 site📍 Beijing Beijing Tide Pharmaceutical Co., Ltd · Tests: CPD704 Inhalation Suspension, CPD704 placebo A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis NCT07038720Phase 11 site📍 Hangzhou Usynova Pharmaceuticals Ltd. · Tests: UA026, Placebo Nalmefene Implant in Healthy Subjects NCT07325279Phase 11 site📍 Morrisville ReacX Pharmaceuticals, Inc. · Tests: 1 Nalmefene implant, 2 Nalmefene implants Study of HX15001 in Adult Healthy Volunteers. NCT06999720Phase 11 site📍 Herston Helixon Biotechnology (Suzhou) Co., Ltd · Tests: HX15001 (SAD), Placebo, HX15001 (MAD), Placebo A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet NCT07374224Phase 11 site📍 Beijing Guangzhou Lupeng Pharmaceutical Company LTD. · Tests: Rocbrutinib tablets, Itraconazole capsules, Rifampicin capsules A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity NCT07437079Phase 11 site📍 Lenexa Novo Nordisk A/S · Tests: NNC6989-0001, Placebo (NNC6989-0001) A Comparison of Fisetin Kinetics in Young and Old Adults NCT06796374NA1 site📍 Greifswald University Medicine Greifswald · Tests: Fisetin - Fasted condition, Fisetin - Fed condition A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects NCT05913752Phase 1, Phase 24 sites📍 New Haven📍 Baltimore📍 Jerusalem Clearmind Medicine Inc. · Tests: CMND-100 Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults NCT07161180Phase 11 site📍 Seoul Pharmbio Korea Co., Ltd. · Tests: PBK_M2301 (levodropropizine + Pelargonium sidoides extract), R1_PBK_M2301 (levodropropizine), R2_PBK_M2301 (Pelargonium… Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects NCT07058779Phase 11 site📍 Shanghai Shenyang Sunshine Pharmaceutical Co., LTD. · Tests: SSS55 To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers NCT07514780Phase 11 site📍 Seoul JW Pharmaceutical · Tests: JW0061 SAD, JW0061 MAD, Placebo Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects NCT06867393Phase 11 site📍 Suzhou Shanghai Kechow Pharma, Inc. · Tests: HL-003 tablet Placeco, HL-003 tablet A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers NCT07162441Phase 11 site📍 Seoul Korea United Pharm. Inc. · Tests: treatment A, treatment B, treatment C A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers NCT07682948Phase 11 site📍 Anyang Korea United Pharm. Inc. · Tests: Investigational Product 1, Investigational Product 2, Investigational Product 1 + Investigational Product 2 A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects. NCT05620940Phase 11 site📍 Herston Inventage Lab., Inc. · Tests: Vivitrol Injectable Product, IVL3004, IVL4002 A Phase I Clinical Study of a Single Dose of KLA480 NCT07030790Phase 11 site📍 Shanghai Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. · Tests: KLA480 injection, Placebo A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants NCT07612020Phase 11 site📍 Mount Royal argenx · Tests: empasiprubart SC AI, empasiprubart IV A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants NCT06655870Phase 11 site📍 Melbourne ModernaTX, Inc. · Tests: mRNA-0184 Phase I Study of HXN6005 in Adult Healthy Participants NCT07449741Phase 11 site📍 Bayswater Helixon Biotechnology (Suzhou) Co., Ltd · Tests: HXN6005, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy